Article
Vaccination against schistosomiasis and fascioliasis with the new recombinant antigen Sm14: potential basis of a multi-valent anti-helminth vaccine?
Registro en:
TENDLER, Miriam et al. Vaccination against schistosomiasis and fascioliasis with the new recombinant antigen Sm14: potential basis of a multi-valent anti-helminth vaccine?. Memórias do Instituto Oswaldo Cruz, Rio de Janeiro, v. 90, n. 2, p. 255-256, Mar./Apr. 1995.
0074-0276
10.1590/S0074-02761995000200022
1678-8060
Autor
Tendler, Miriam
Vilar, Monica Magno
Brito, Cristiana Alves
Freire, Nicolau Maués da Serra
Katz, Naftale
Simpson, Andrew
Resumen
Molecular cloning of components of protective antigenic preparations have suggested that related parasite fatty acid binding proteins could form the basis of the well documented protective, immune cross reactivity between the parasitic trematode worms Fasciola hepatica and Schistosoma mansoni. We have now confirmed the cross protective potential of parasite fatty acid binding proteins and suggest that it may be possible to produce a single vaccine that would be effective against at least two parasites, F. hepatica and S. mansoni of veterinary and human importance respectively.